RCEL
Avita Medical LtdNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$125.59M
P/E Ratio
—
EPS
$-1.85
Beta
1.89
52W High
$10.29
52W Low
$3.22
50-Day MA
$4.36
200-Day MA
$4.49
Dividend Yield
—
Profit Margin
-67.80%
Forward P/E
9.10
PEG Ratio
—
About Avita Medical Ltd
AVITA Medical Inc. is a commercial stage regenerative tissue company in the United States, Australia, and the United Kingdom. The company is headquartered in Valencia, California.
Fundamentals
| Revenue (TTM) | $71.61M |
| Gross Profit (TTM) | $58.82M |
| EBITDA | $-40.24M |
| Operating Margin | -59.10% |
| Return on Equity | -1746.00% |
| Return on Assets | -39.10% |
| Revenue/Share (TTM) | $2.57 |
| Book Value | $-0.55 |
| Price-to-Book | 11.77 |
| Price-to-Sales (TTM) | 1.75 |
| EV/Revenue | 1.976 |
| EV/EBITDA | -6.17 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -4.30% |
| Shares Outstanding | $30.63M |
| Float | $30.28M |
| % Insiders | 1.41% |
| % Institutions | 15.82% |
Analyst Ratings
Consensus ($8.53 target)
3
Buy1
HoldData last updated: 4/9/2026